Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3586713

CCc1nc(C)cn1CC(=O)O.O=C(O)C(F)(F)F

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.51
KDM4E B2RXH2 2/20 0.36
MAPT P10636 2/20 0.36
ALDH1A1 P00352 1/20 0.36
POLB P06746 1/20 0.36
LMNA P02545 3/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
PPARD Q03181 2/20 0.33
PPARA Q07869 2/20 0.33
AKR1A1 P14550 1/20 0.33
AKR1B1 P15121 1/20 0.33
PTGDR2 Q9Y5Y4 2/20 0.32
PDE4A P27815 1/20 0.32
PDE4B Q07343 1/20 0.32
PDE4C Q08493 1/20 0.32
PDE4D Q08499 1/20 0.32
MEN1 O00255 1/20 0.32
ABCC4 O15439 1/20 0.32
PKM P14618 1/20 0.32
PTGS1 P23219 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13031308 0.91 CYP19A1 (0.58) CYP19A1KDM4EMAPTALDH1A1POLB
Trifluoroacetic Acid SCHEMBL3583791 0.83 KDM4E (0.39) CYP19A1KDM4EMAPTALDH1A1POLB
SCHEMBL26919578 0.78 CYP19A1 (0.47) CYP19A1KDM4EMAPTALDH1A1POLB
Trifluoroacetic Acid SCHEMBL16700571 0.76 ALDH1A1 (0.44) CYP19A1KDM4EALDH1A1LMNAMEN1
SCHEMBL25404336 0.76 CYP19A1 (0.43) CYP19A1KDM4ELMNAMEN1KMT2A
SCHEMBL25401555 0.75 CYP19A1 (0.49) CYP19A1KDM4EMAPTALDH1A1LMNA
SCHEMBL3591115 0.73 CYP19A1 (0.45) CYP19A1KDM4EMAPTALDH1A1LMNA
SCHEMBL6855316 0.73 CYP19A1 (0.47) CYP19A1KDM4EMAPTALDH1A1LMNA
SCHEMBL4453709 0.72 ALDH1A1 (0.46) CYP19A1KDM4EMAPTALDH1A1POLB
Trifluoroacetic Acid SCHEMBL3586206 0.72 KDM4E (0.37) KDM4EMAPTALDH1A1POLBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100286191-A1 2-Arylthiazole Derivatives as CXCR3 Receptor Modulators MERCK SHARP & DOHME CORP. 2010-11-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100286191-A1 2-Arylthiazole Derivatives as CXCR3 Receptor Modulators CXCR3, CXCR1, CXCR2 CYP19A1 3384/4885KDM4E 3447/4885MAPT 4292/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.